Open Access

Paroxysmal spasticity of lower extremities as the initial symptom in two siblings with maple syrup urine disease

  • Authors:
    • Yi‑Dan Liu
    • Xu Chu
    • Rui‑Hua Liu
    • Ying Sun
    • Qing‑Xia Kong
    • Qiu‑Bo Li
  • View Affiliations

  • Published online on: April 5, 2019     https://doi.org/10.3892/mmr.2019.10133
  • Pages: 4872-4880
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Maple syrup urine disease (MSUD) is a rare autosomal recessive metabolic disorder caused by mutations in genes that encode subunits of the branched‑chain α‑ketoacid dehydrogenase (BCKD) complex. Impairment of the BCKD complex results in an abnormal accumulation of branched‑chain amino acids and their corresponding branched‑chain keto acids in the blood and cerebrospinal fluid, which are neurovirulent and may become life‑threatening. An 11‑day‑old boy was admitted to the hospital with paroxysmal spasticity of lower extremities. Of note, his 10‑year‑old sister presented similar symptoms during the neonatal period, and her condition was diagnosed as MSUD when she was 1.5 years old. Genetic screening was performed, and the boy and his sister exhibited two novel compound heterozygous mutations in the branched chain keto acid dehydrogenase E1 subunit β (BCKDHB) gene: A substitution from guanine to adenine in the coding region at position 1,076 (c.1,076G>A) in exon 10 and a deletion of a thymine at position 705 (c.705delT) in exon 6. The missense mutation c.1076G>A results in an amino acid substitution from arginine to lysine at position 359 (p.Arg359Lys), whereas the mutation c.705delT results in the replacement of a cysteine at position 235 with a stop codon (p.Cys235Ter). Neither of the BCKDHB alleles in the compound heterozygote patients is able to generate normal E1β subunits, resulting in a possible impairment of the activity of the BCKD complex. In the present study, it was hypothesized that the two novel heterozygous mutations in the BCKDHB gene found in the Chinese family may be responsible for the phenotype of the two siblings with MSUD.

References

1 

Sperringer JE, Addington A and Hutson SM: Branched-chain amino acids and brain metabolism. Neurochem Res. 42:1697–1709. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Menkes JH, Hurst PL and Craig JM: A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics. 14:462–467. 1954.PubMed/NCBI

3 

Wasim M, Awan FR, Khan HN, Tawab A, Iqbal M and Ayesha H: Aminoacidopathies: Prevalence, etiology, screening, and treatment options. Biochem Genet. 56:7–21. 2018. View Article : Google Scholar : PubMed/NCBI

4 

Tabbouche O, Saker A and Mountain H: Identification of three novel mutations by studying the molecular genetics of maple syrup urine disease (MSUD) in the lebanese population. Mol Genet Metab Rep. 1:273–279. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Rodan LH, Aldubayan SH, Berry GT and Levy HL: Acute illness protocol for maple syrup urine disease. Pediatr Emerg Care. 34:64–67. 2018. View Article : Google Scholar : PubMed/NCBI

6 

Puckett RL, Lorey F, Rinaldo P, Lipson MH, Matern D, Sowa ME, Levine S, Chang R, Wang RY and Abdenur JE: Maple syrup urine disease: Further evidence that newborn screening may fail to identify variant forms. Mol Genet Metab. 100:136–142. 2010. View Article : Google Scholar : PubMed/NCBI

7 

Su L, Lu Z, Li F, Shao Y, Sheng H, Cai Y and Liu L: Two homozygous mutations in the exon 5 of BCKDHB gene that may cause the classic form of maple syrup urine disease. Metab Brain Dis. 32:765–772. 2017. View Article : Google Scholar : PubMed/NCBI

8 

Li X, Ding Y, Liu Y, Ma Y, Song J, Wang Q, Li M, Qin Y and Yang Y: Eleven novel mutations of the BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease in the Chinese population: Report on eight cases. Eur J Med Genet. 58:617–623. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Sowell J, Pollard L and Wood T: Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease. J Sep Sci. 34:631–639. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Wechsler D: Wechsler Intelligence Scale for Children. 5th. NCS Pearson; San Antonio, TX: 2014

11 

Li H: Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv preprint arXiv. 1303.3997v2. 2013.

12 

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M and DePristo MA: The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20:1297–1303. 2010. View Article : Google Scholar : PubMed/NCBI

13 

D'Angelo R, Donato L, Venza I, Scimone C, Aragona P and Sidoti A: Possible protective role of the ABCA4 gene c.1268A>G missense variant in Stargardt disease and syndromic retinitis pigmentosa in a Sicilian family: Preliminary data. Int J Mol Med. 39:1011–1020. 2017. View Article : Google Scholar : PubMed/NCBI

14 

Hoffmann GF and Kölker S: Defects in amino acid catabolism and the urea cycle. Handb Clin Neurol. 113:1755–1773. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al: Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 17:405–424. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Lindqvist Y, Schneider G, Ermler U and Sundström M: Three-dimensional structure of transketolase, a thiamine diphosphate dependent enzyme, at 2.5 A resolution. EMBO J. 11:2373–2379. 1992. View Article : Google Scholar : PubMed/NCBI

17 

AEvarsson A, Chuang JL, Wynn RM, Turley S, Chuang DT and Hol WG: Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure. 8:277–291. 2000. View Article : Google Scholar : PubMed/NCBI

18 

Bashyam MD, Chaudhary AK, Sinha M, Nagarajaram HA, Devi AR, Bashyam L, Reddy EC and Dalal A: Molecular genetic analysis of MSUD from India reveals mutations causing altered protein truncation affecting the C-termini of E1α and E1β. J Cell Biochem. 113:3122–3132. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Edelmann L, Wasserstein MP, Kornreich R, Sansaricq C, Snyderman SE and Diaz GA: Maple syrup urine disease: Identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population. Am J Hum Genet. 69:863–868. 2001. View Article : Google Scholar : PubMed/NCBI

20 

Guo Y, Liming L and Jiang L: Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease. Metab Brain Dis. 30:1395–1400. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Zinnanti WJ, Lazovic J, Griffin K, Skvorak KJ, Paul HS, Homanics GE, Bewley MC, Cheng KC, Lanoue KF and Flanagan JM: Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain. 132:903–918. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Sitta A, Ribas GS, Mescka CP, Barschak AG, Wajner M and Vargas CR: Neurological damage in MSUD: The role of oxidative stress. Cell Mol Neurobiol. 34:157–165. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Wang YP, Qi ML, Li TT and Zhao YJ: Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD). Gene. 498:112–115. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Simon E, Schwarz M and Wendel U: Social outcome in adults with maple syrup urine disease (MSUD). J Inherit Metab Dis. 30:2642007. View Article : Google Scholar : PubMed/NCBI

25 

Blackburn PR, Gass JM, Vairo FPE, Farnham KM, Atwal HK, Macklin S, Klee EW and Atwal PS: Maple syrup urine disease: Mechanisms and management. Appl Clin Genet. 10:57–66. 2017. View Article : Google Scholar : PubMed/NCBI

26 

Kilicarslan R, Alkan A, Demirkol D, Toprak H and Sharifov R: Maple syrup urine disease: Diffusion-weighted MRI findings during acute metabolic encephalopathic crisis. Jpn J Radiol. 30:522–525. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Schönberger S, Schweiger B, Schwahn B, Schwarz M and Wendel U: Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab. 82:69–75. 2004. View Article : Google Scholar : PubMed/NCBI

28 

Brown G: Defects of thiamine transport and metabolism. J Inherit Metab Dis. 37:577–585. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Mescka CP, Guerreiro G, Donida B, Marchetti D, Wayhs CA, Ribas GS, Coitinho AS, Wajner M, Dutra-Filho CS and Vargas CR: Investigation of inflammatory profile in MSUD patients: Benefit of L-carnitine supplementation. Metab Brain Dis. 30:1167–1174. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Ribas GS, Vargas CR and Wajner M: L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene. 533:469–476. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Li X, Yang Y, Gao Q, Gao M, Lv Y, Dong R, Liu Y, Zhang K and Gai Z: Clinical characteristics and mutation analysis of five Chinese patients with maple syrup urine disease. Metab Brain Dis. 33:741–751. 2018. View Article : Google Scholar : PubMed/NCBI

32 

Díaz VM, Camarena C, de la Vega Á, Martínez-Pardo M, Díaz C, López M, Hernández F, Andrés A and Jara P: Liver transplantation for classical maple syrup urine disease: Long-term follow-up. J Pediatr Gastroenterol Nutr. 59:636–639. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Bouchereau J, Leduc-Leballeur J, Pichard S, Imbard A, Benoist JF, Abi Warde MT, Arnoux JB, Barbier V, Brassier A, Broué P, et al: Neurocognitive profiles in MSUD school-age patients. J Inherit Metab Dis. 40:377–383. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 19 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liu, Y., Chu, X., Liu, R., Sun, Y., Kong, Q., & Li, Q. (2019). Paroxysmal spasticity of lower extremities as the initial symptom in two siblings with maple syrup urine disease. Molecular Medicine Reports, 19, 4872-4880. https://doi.org/10.3892/mmr.2019.10133
MLA
Liu, Y., Chu, X., Liu, R., Sun, Y., Kong, Q., Li, Q."Paroxysmal spasticity of lower extremities as the initial symptom in two siblings with maple syrup urine disease". Molecular Medicine Reports 19.6 (2019): 4872-4880.
Chicago
Liu, Y., Chu, X., Liu, R., Sun, Y., Kong, Q., Li, Q."Paroxysmal spasticity of lower extremities as the initial symptom in two siblings with maple syrup urine disease". Molecular Medicine Reports 19, no. 6 (2019): 4872-4880. https://doi.org/10.3892/mmr.2019.10133